Point Sur Investors

Investing in Innovation

Our INVESTMENT Philosophy

Biopharmaceutical companies have the potential to discover and to develop innovative medicines, which have a significant impact on patients to overcome serious and life-threatening diseases. The discovery and successful development of such breakthrough therapies leads to unusually strong and long-lasting value appreciation of a firm’s equity.
 
Due to the vast complexities involved in drug development, new therapies and their development progress are often misunderstood by investors and analysts, resulting in investment opportunities due to improper valuations. 
 
Drug discovery and development however, is a very complex and dynamic process. A high level of technical, business and legal acumen is required to successfully navigate a company through the discovery, clinical development, regulatory approval, and commercialization of a novel therapy. As a consequence, a very small percentage of discovered drugs actually make it past approval and into commercialization.

Privacy Policy    |    Terms of Use

Point Sur Investors LLC (PSI) is an independent, privately held investment advisor located in Palo Alto, California. The materials herein are intended solely for the recipient of the password and neither the materials nor the password may be transmitted to any other person without Point Sur Investors’ consent. This website is neither an offer to sell nor a solicitation of an offer to buy any security.

 

Copyright © 2015 Point Sur Investors LLC. All rights reserved.

926B Emerson St. Palo Alto, CA 94301 | Phone: 650-600-8302